Summary
Medtronic plc announced on November 2, 2025, that its Executive Vice President, Enterprise Operations, Gregory L. Smith, will retire from the company effective December 2, 2025. Mr. Smith's departure marks a leadership transition within the company's operations segment. Investors should note that his retirement triggers specific provisions regarding his outstanding equity compensation, as detailed in the company's filings.
Key Highlights
- 1Gregory L. Smith, EVP, Enterprise Operations, is retiring effective December 2, 2025.
- 2Mr. Smith is moving to a private equity-held organization.
- 3Upon retirement, Mr. Smith will receive retirement treatment for his outstanding equity compensation.
- 4This includes acceleration of unvested stock options.
- 5Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) will continue vesting as per award agreements.
- 6Details on equity compensation treatment are available in the company's August 25, 2025 proxy statement and publicly filed award agreements.
Frequently Asked Questions
Gregory L. Smith, Executive Vice President of Enterprise Operations, is retiring from Medtronic.
His retirement is effective December 2, 2025.
Mr. Smith will be eligible for retirement treatment on his outstanding equity compensation. This involves the acceleration of unvested stock options and the continued vesting of RSUs and PSUs, consistent with the terms of the award agreements.
Details regarding the retirement treatment of equity compensation can be found in Medtronic's definitive proxy statement filed on August 25, 2025, and the associated equity award agreements filed with the SEC.